Blood Test to Guide Colorectal Cancer Follow-Up Treatment
Part of Cancer, Digestive system clinical trials.
This trial tests whether a special blood test that detects cancer DNA can help doctors decide if you need additional chemotherapy after colorectal cancer surgery. The goal is to personalize treatment based on your individual risk rather than giving chemotherapy to everyone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Had colorectal cancer surgery followed by a blood test showing cancer DNA present 1 month after surgery
- Your doctor confirms your cancer stage and that you're healthy enough for treatment (expected to live more than 1 year)
- No cancer chemotherapy before your surgery
- No other cancer diagnoses in the past 5 years (except skin cancer or cervical precancer)
- No severe heart disease, active infections, or other serious medical conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a simple blood test to detect cancer DNA after surgery for early-stage colon cancer. The goal is to help doctors decide whether chemotherapy is truly needed based on the blood test results, rather than giving it to everyone.
This study tests whether a special blood test (looking for cancer DNA) can help doctors decide if you need chemotherapy after colorectal cancer surgery. The goal is to avoid unnecessary chemotherapy while making sure patients who need it get treated.
This study helps doctors decide whether you need chemotherapy after colon cancer surgery by checking for cancer DNA in your blood. The goal is to give chemotherapy only to patients who truly need it, based on what the blood test shows.
This trial studies whether adding CAPEOX chemotherapy after surgery can help people with colon cancer who have a “positive MRD” blood test result (meaning tiny amounts of cancer may still be present). It compares chemo versus active observation to see if chemo improves outcomes while keeping safety in mind.
This study uses a blood test to check for tumor DNA after surgery, which may help doctors decide if you need additional chemotherapy. It is for people with stage 3 colorectal cancer that is removed by surgery.
This Phase 3 trial tests whether an added “maintenance” treatment after liver surgery can help prevent colorectal cancer from coming back. It is only for people whose blood test (ctDNA) still shows signs of cancer after their operation.
Hear when a new ctDNA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.